Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Condition: Multiple SclerosisInterventions: Drug: BIIB033; Other: Placebo; Drug: Interferon Beta-1aSponsor: Biogen IdecActive, not recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials